Lilly to Participate in J.P. Morgan Healthcare Conference

On January 2, 2024 Eli Lilly and Company (NYSE: LLY) reported that it will attend the 42nd Annual J.P. Morgan Healthcare Conference, Jan. 8-11, 2024 (Press release, Eli Lilly, JAN 2, 2024, View Source [SID1234638862]). David A. Ricks, Lilly’s chair and CEO, will participate in a fireside chat on Jan. 9 at 5:15 p.m. Eastern time.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live audio webcast will be available on the "Webcasts & Presentations" section of Lilly’s Investor website at View Source A replay of the presentation will be available on this same website for approximately 30 days.